These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 21659770

  • 1. Study of diabetic nephropathy in the proteomic era.
    Thongboonkerd V.
    Contrib Nephrol; 2011; 170():172-183. PubMed ID: 21659770
    [Abstract] [Full Text] [Related]

  • 2. Searching for novel biomarkers and new therapeutic targets of diabetic nephropathy using proteomics approaches.
    Thongboonkerd V.
    Contrib Nephrol; 2008; 160():37-52. PubMed ID: 18401160
    [Abstract] [Full Text] [Related]

  • 3. Proteomics and diabetic nephropathy.
    Merchant ML, Klein JB.
    Curr Diab Rep; 2005 Dec; 5(6):464-9. PubMed ID: 16316599
    [Abstract] [Full Text] [Related]

  • 4. Proteomics and diabetic nephropathy.
    Merchant ML, Klein JB.
    Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
    [Abstract] [Full Text] [Related]

  • 5. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 6. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y.
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [Abstract] [Full Text] [Related]

  • 7. Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry.
    Smith A, Iablokov V, Mazza M, Guarnerio S, Denti V, Ivanova M, Stella M, Piga I, Chinello C, Heijs B, van Veelen PA, Benediktsson H, Muruve DA, Magni F.
    Kidney Blood Press Res; 2020 Mar; 45(2):233-248. PubMed ID: 32062660
    [Abstract] [Full Text] [Related]

  • 8. Diabetic nephropathy: traditional to proteomic markers.
    Moresco RN, Sangoi MB, De Carvalho JA, Tatsch E, Bochi GV.
    Clin Chim Acta; 2013 Jun 05; 421():17-30. PubMed ID: 23485645
    [Abstract] [Full Text] [Related]

  • 9. [Novel biomarkers for diabetic nephropathy].
    Araki S.
    Rinsho Byori; 2014 Feb 05; 62(2):171-9. PubMed ID: 24800493
    [Abstract] [Full Text] [Related]

  • 10. [Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
    Beige J, Drube J, von der Leyen H, Pape L, Rupprecht H.
    Internist (Berl); 2020 Oct 05; 61(10):1094-1105. PubMed ID: 32897404
    [Abstract] [Full Text] [Related]

  • 11. New insights into the use of biomarkers of diabetic nephropathy.
    Jha JC, Jandeleit-Dahm KA, Cooper ME.
    Adv Chronic Kidney Dis; 2014 May 05; 21(3):318-26. PubMed ID: 24780461
    [Abstract] [Full Text] [Related]

  • 12. Urine proteome analysis by C18 plate-matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy.
    Chen CJ, Liao WL, Chang CT, Liao HY, Tsai FJ.
    PLoS One; 2018 May 05; 13(7):e0200945. PubMed ID: 30024955
    [Abstract] [Full Text] [Related]

  • 13. Potential biomarkers associated with diabetic glomerulopathy through proteomics.
    Hsu YC, Lei CC, Ho C, Shih YH, Lin CL.
    Ren Fail; 2015 May 05; 37(8):1308-15. PubMed ID: 26364511
    [Abstract] [Full Text] [Related]

  • 14. Insights into predicting diabetic nephropathy using urinary biomarkers.
    Khan NU, Lin J, Liu X, Li H, Lu W, Zhong Z, Zhang H, Waqas M, Shen L.
    Biochim Biophys Acta Proteins Proteom; 2020 Oct 05; 1868(10):140475. PubMed ID: 32574766
    [Abstract] [Full Text] [Related]

  • 15. Potential Role of N-Cadherin in Diagnosis and Prognosis of Diabetic Nephropathy.
    Ali H, Abu-Farha M, Hammad MM, Devarajan S, Bahbahani Y, Al-Khairi I, Cherian P, Alsairafi Z, Vijayan V, Al-Mulla F, Attar AA, Abubaker J.
    Front Endocrinol (Lausanne); 2022 Oct 05; 13():882700. PubMed ID: 35712247
    [Abstract] [Full Text] [Related]

  • 16. Proteomic profiling of laser capture microdissection kidneys from diabetic nephropathy patients.
    Yang Z, Chen L, Huang Y, Dong J, Yan Q, Li Y, Qiu J, Li H, Zhao D, Liu F, Tang D, Dai Y.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Aug 01; 1243():124231. PubMed ID: 38996754
    [Abstract] [Full Text] [Related]

  • 17. Early detection and treatment of diabetic nephropathy.
    Woredekal Y.
    Pediatr Endocrinol Rev; 2008 Aug 01; 5 Suppl 4():999-1004. PubMed ID: 18806717
    [Abstract] [Full Text] [Related]

  • 18. Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy.
    Currie G, Delles C.
    Curr Diab Rep; 2016 Nov 01; 16(11):104. PubMed ID: 27658932
    [Abstract] [Full Text] [Related]

  • 19. Biomarkers of diabetic nephropathy, the present and the future.
    Jim B, Santos J, Spath F, Cijiang He J.
    Curr Diabetes Rev; 2012 Sep 01; 8(5):317-28. PubMed ID: 22698077
    [Abstract] [Full Text] [Related]

  • 20. Proteomic profile in glomeruli of type-2 diabetic KKAy mice using 2-dimensional differential gel electrophoresis.
    Liu X, Yang G, Fan Q, Wang L.
    Med Sci Monit; 2014 Dec 17; 20():2705-13. PubMed ID: 25515740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.